By designating just one reference stated drug as being the common to which all generic versions need to be demonstrated to become bioequivalent, FDA hopes in order to avoid achievable significant versions amongst generic drugs as well as their model name counterpart. Bear in mind, continue to keep this and all other medicines out from the get to